220 related articles for article (PubMed ID: 21615918)
1. Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients.
Sigalotti L; Fratta E; Bidoli E; Covre A; Parisi G; Colizzi F; Coral S; Massarut S; Kirkwood JM; Maio M
J Transl Med; 2011 May; 9():78. PubMed ID: 21615918
[TBL] [Abstract][Full Text] [Related]
2. Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients.
Sigalotti L; Covre A; Fratta E; Parisi G; Sonego P; Colizzi F; Coral S; Massarut S; Kirkwood JM; Maio M
J Transl Med; 2012 Sep; 10():185. PubMed ID: 22950745
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic markers of prognosis in melanoma.
Sigalotti L; Fratta E; Parisi G; Coral S; Maio M
Methods Mol Biol; 2014; 1102():481-99. PubMed ID: 24258994
[TBL] [Abstract][Full Text] [Related]
4. AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.
Hoshimoto S; Kuo CT; Chong KK; Takeshima TL; Takei Y; Li MW; Huang SK; Sim MS; Morton DL; Hoon DS
J Invest Dermatol; 2012 Jun; 132(6):1689-97. PubMed ID: 22402438
[TBL] [Abstract][Full Text] [Related]
5. Long interspersed nucleotide element-1 hypomethylation in canine malignant mucosal melanoma.
Ishizaki T; Yamazaki J; Meagawa S; Yokoyama N; Aoshima K; Takiguchi M; Kimura T
Vet Comp Oncol; 2020 Dec; 18(4):854-860. PubMed ID: 32187810
[TBL] [Abstract][Full Text] [Related]
6. LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis.
Shigaki H; Baba Y; Watanabe M; Murata A; Iwagami S; Miyake K; Ishimoto T; Iwatsuki M; Baba H
Gastric Cancer; 2013 Oct; 16(4):480-7. PubMed ID: 23179365
[TBL] [Abstract][Full Text] [Related]
7. A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma.
Guo W; Zhu L; Zhu R; Chen Q; Wang Q; Chen JQ
Elife; 2019 Jun; 8():. PubMed ID: 31169496
[TBL] [Abstract][Full Text] [Related]
8. Association of HERV-K and LINE-1 hypomethylation with reduced disease-free survival in melanoma patients.
Cardelli M; Doorn RV; Larcher L; Donato MD; Piacenza F; Pierpaoli E; Giacconi R; Malavolta M; Rachakonda S; Gruis NA; Molven A; Andresen PA; Pjanova D; van den Oord JJ; Provinciali M; Nagore E; Kumar R
Epigenomics; 2020 Oct; 12(19):1689-1706. PubMed ID: 33125285
[No Abstract] [Full Text] [Related]
9. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.
Harada K; Baba Y; Ishimoto T; Chikamoto A; Kosumi K; Hayashi H; Nitta H; Hashimoto D; Beppu T; Baba H
Ann Surg Oncol; 2015 Apr; 22(4):1280-7. PubMed ID: 25319577
[TBL] [Abstract][Full Text] [Related]
10. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
[TBL] [Abstract][Full Text] [Related]
11. LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Sakamaki K; Ohashi Y; Baba H
Ann Surg; 2013 Mar; 257(3):449-55. PubMed ID: 23023202
[TBL] [Abstract][Full Text] [Related]
12. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
[TBL] [Abstract][Full Text] [Related]
13. The Effects of O
Yildiz OG; Aslan D; Akalin H; Erdem Y; Canoz O; Aytekin A; Ozoner S; Dundar M
Balkan J Med Genet; 2020 Jun; 23(1):33-41. PubMed ID: 32953407
[TBL] [Abstract][Full Text] [Related]
14. LINE-1 methylation in peripheral blood and the risk of melanoma in melanoma-prone families with and without CDKN2A mutations.
Hyland PL; Burke LS; Pfeiffer RM; Mirabello L; Tucker MA; Goldstein AM; Yang XR
Melanoma Res; 2013 Feb; 23(1):55-60. PubMed ID: 23222549
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH
Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer.
Kaneko M; Kotake M; Bando H; Yamada T; Takemura H; Minamoto T
BMC Cancer; 2016 Dec; 16(1):945. PubMed ID: 27955637
[TBL] [Abstract][Full Text] [Related]
17. LINE-1 hypomethylation and mutational status in cutaneous melanomas.
Pramio DT; Pennacchi PC; Maria-Engler SS; Campos AH; Duprat JP; Carraro DM; Krepischi AC
J Investig Med; 2016 Apr; 64(4):899-904. PubMed ID: 26965315
[TBL] [Abstract][Full Text] [Related]
18. Transposable hypomethylation is associated with metastatic capacity of primary melanomas.
Ecsedi SI; Hernandez-Vargas H; Lima SC; Herceg Z; Adany R; Balazs M
Int J Clin Exp Pathol; 2013; 6(12):2943-8. PubMed ID: 24294382
[TBL] [Abstract][Full Text] [Related]
19. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
[TBL] [Abstract][Full Text] [Related]
20. Long interspersed nuclear element-1 hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma.
Lee YR; Kim G; Lee HW; Tak WY; Park SY; Jang SY; Kweon YO; Park JG; Han YS; Chun JM; Han JR; Hur K
Medicine (Baltimore); 2021 Apr; 100(16):e25552. PubMed ID: 33879706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
